Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients.
Kokot
F
F
Department of Nephrology, Silesian School of Medicine, Katowice, Poland.
Wiecek
A
A
Grzeszczak
W
W
Klepacka
J
J
Klin
M
M
Lao
M
M
D000328:Adult; D000740:Anemia / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D004702:Endocrine Glands / Q000187:drug effects* / Q000503:physiopathology; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006728:Hormones / Q000097:blood; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010913:Pituitary-Adrenal System / Q000187:drug effects; D006435:Renal Dialysis; D012084:Renin-Angiotensin System / Q000187:drug effects; D014511:Uremia / Q000150:complications / Q000503:physiopathology / Q000628:therapy
D006728:Hormones; D004921:Erythropoietin